Trials / Unknown
UnknownNCT02020161
Clinical Guidelines for APL Treatment
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- PETHEMA Foundation · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Therapeutic guidelines for treatment of patients with de novo APL to be used by every institution that wants to follow them. All patients who are reported may be retrospectively analyzed
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atra | |
| DRUG | Idarubicin | |
| DRUG | methotrexate |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2013-12-24
- Last updated
- 2021-03-23
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02020161. Inclusion in this directory is not an endorsement.